Skip to main content

Table 1 Characteristics of patients and controls

From: Histological validation of cardiovascular magnetic resonance T1 mapping markers of myocardial fibrosis in paediatric heart transplant recipients

 

Patients

Controls

p

(n = 20)

(n = 24)

Male/female

11/9

12/12

0.74

Age at CMR, y

9.9 ± 6.2

13.9 ± 2.6

<0.05

Heart age at CMR, y

13.8 ± 9.3

13.9 ± 2.6

0.95

Body surface area, m2

1.19 ± 0.59

1.63 ± 0.28

<0.01

Heart rate at CMR, bpm

98 ± 12

76 ± 10

<0.0001

Hematocrit, %

36.9 ± 5.3

42.1 ± 3.6

<0.0005

NT-proBNP, pg/ml

49 (5–531)

NA

NA

Time since HTx at CMR, y

1.3 (0.02–12.6)

NA

NA

Ischemia Time, mina

207 ± 82 (n = 19)

NA

NA

Peak oxygen uptake (% of predicted)

66 ± 18 (n = 13)

NA

NA

Peak workload (% of predicted)

53 ± 5 (n = 13)

NA

NA

  1. Data are expressed as mean and standard deviation except for time since HTx and NT-proBNP (reported in median and range)
  2. Abbreviations: NT-proBNP N-terminal probrain natriuretic peptide, CMR cardiovascular magnetic resonance, HTx heart transplantation
  3. aData were available in 19 of 20 patients